Keep their respective responsibilities and form a pattern of joint development

On August 1, at the expert symposium sponsored by China Pharmaceutical News, experts, scholars and industry representatives agreed that the special action of "two dozen and two constructions", which is being carried out by the State Food and drug administration, is very timely and necessary, and drug production and trading enterprises, medical institutions and drug regulatory departments should each abide by their responsibilities and be strict Close cooperation to ensure that people eat safe and effective traditional Chinese medicine Wu Zhen, deputy director of the State Food and drug administration, attended the symposium It is reported that the State Administration is carrying out a special action of "two dozen and two constructions" with the main contents of cracking down on illegal drug production, cracking down on illegal drug trade, strengthening the construction of drug production and trade norms and the construction of drug regulatory mechanism, among which the rectification of specialized market of Chinese herbal medicine is an important part "As an industry association, we firmly support this" two strikes and two constructions "special action." Fang Shuting, President of the China Association of traditional Chinese medicine, suggested that we should take good care of the market of traditional Chinese medicine First, we should implement the responsibilities of governments at all levels and the management departments of the market of traditional Chinese medicine Second, we should study and formulate the access system for the operators of the market of traditional Chinese medicine and raise the threshold of the market of traditional Chinese medicine "Our hospital uses a lot of pieces of Chinese herbal medicine in a year, and there is a lot of pressure to ensure the quality As a terminal, we support the special action of" two dozen and two construction " Wang Lixia, director of Pharmacy Department of Guang'anmen Hospital, Chinese Academy of traditional Chinese medicine, suggested that we should guide the healthy development of traditional Chinese medicine industry from the source of planting and processing, strengthen price management, prevent idle funds from hyping traditional Chinese medicine, and ensure clinical use of drugs "There is no future for the traditional Chinese medicine industry to rely on the old pharmaceutical workers for a long time We must rely on standardization This special action of "two strikes and two constructions" is very innovative It has both breakthroughs and achievements There are still some battles and constructions " Jiang Yun, chairman of the board of directors of Sichuan xinhehua price Herbal Pieces Co., Ltd., suggested that large varieties and enterprises of herbal pieces should be encouraged to form; in addition to the production and circulation links, the medical institutions purchasing unqualified herbal medicines should also be firmly exposed, and the punishment should be increased, and the upstream production enterprises should be forced to improve the quality from the terminal "The special action of" two dozen and two construction "is not to increase the burden on Chinese patent medicine manufacturers, but to increase the protection for law-abiding enterprises It is too timely." Zhao bubo, chairman of bubo pharmaceutical, pointed out that drugs are special commodities, which are related to the lives of patients and enterprises He suggested that bad enterprises should be firmly banned, illegal and law-abiding enterprises should be combated, and people should be encouraged to form reassuring pharmaceutical enterprises "The special action of" two strikes and two constructions "carried out by the General Administration of China is unprecedented in both the determination of rectification and the intensity of strike, which will play a positive role in further standardizing the market of traditional Chinese medicine and the production of traditional Chinese patent medicine, and promoting the sustainable and healthy development of the pharmaceutical industry." Liang Yuantai, deputy general manager of Yangtze River Pharmaceutical Group, suggested that the State Administration should combine the special action of "two dozen and two construction" with the implementation of enterprise grading evaluation standards, so that the rating results can play a guiding role in the process of product declaration, product pricing and market bidding After listening to the speeches of experts, scholars and representatives of the industry, Wu Zhen said that the special action of "two strikes and two constructions" is to crack down on the illegal activities in the field of drug production and marketing, intensify the efforts to rectify the possible systemic risks, and resolutely deal with the problems found Second, we need to establish a scientific and efficient regulatory mechanism, start from the source, establish various norms for the production and management of Chinese herbal medicines, and strive to solve long-term problems "Whether it is to fight or to build, it needs the support of industry associations, pharmaceutical production and operation enterprises and users, and a pattern of joint fight and construction should be formed." Wu Zhen pointed out that the first person responsible for drug safety is the drug manufacturing enterprise, which should make sure that unqualified drugs do not enter the factory and unqualified products do not leave the factory; medical institutions should strictly control the purchase to ensure the quality of purchased drugs; drug regulatory departments should establish norms and mechanisms to resolutely crack down on illegal behaviors Experts from China Association of traditional Chinese medicine, China Chamber of Commerce for the import and export of medical and health products, Chinese Academy of traditional Chinese medicine and other associations and units, relevant directors of Beijing Hospital of traditional Chinese Medicine Affiliated to Capital Medical University, Dongzhimen Hospital of Beijing University of traditional Chinese medicine and other medical institutions, representatives of more than ten pharmaceutical enterprises, such as Guangxi Wuzhou Pharmaceutical Co., Ltd., Bubu pharmaceutical, Yiling pharmaceutical and Yangzijiang pharmaceutical of Zhongheng group Table attended the symposium.